Cambridge Endoscopic Devices Inc. and Stemgent Inc. each made quick gains from multi-million dollar equity offerings that opened April 30.
Cambridge Endo, an endoscopic surgical tool maker based in Framingham, Mass., sold to one individual $3 million of a $7.5 million offering, according to Securities & Exchange Commission filings. CEO Woojin Lee and directors Walter Winshall and Phil Henderson were listed as principals in the deal.
Less than a year ago, Cambridge Endo raised $1.5 million in debt financing.
Stem cell firm Stemgent Inc., based in Cambridge, Mass., sold $5.6 million of a proposed $10.1 million offering. Six individuals bought stakes in the company for no less than $500,000, according to an SEC filing. The filing lists Stefan Miltenyi of Miltenyi Biotec as a director. Miltenyi was inducted onto Stemgent’s board when Stemgent and his company this month inked a development and marketing deal.
Other principals named in the filing are CEO Ian Ratcliffe and directors Harold Werner and Augustine Lawlor, both of HealthCare Ventures, and Ralph Christoffersen of Cleveland-based Morganthaler Partners VIII LP.
